Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Copyright © 2022 The Korean Liver Cancer Association
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Conflicts of Interest
The authors have no conflicts to disclose.
Ethics Statement
The study protocol conformed to the ethical guidelines of the Declaration of Helsinki and was approved by the Institutional Review Board (IRB) of Samsung Medical Center (IRB No. SMC 2022-05-076). The need for informed consent was waived by the IRB of Samsung Medical Center due to the retrospective nature of the study
Funding Statement
This study was supported by the Scientific Research Fund of the Korean Liver Cancer Association (2021).
Data Availability
The data presented in this study are available upon request from the corresponding authors.
Author Contribution
Conceptualization: SJJ, JR
Data curation: SJJ
Formal analysis: SJJ, JR
Investigation: SJJ
Methodology: SJJ, JR
Project administration: JWJ
Resources: JR, JMK, G-SC, JWJ
Supervision: JMK, G-SC, JWJ
Validation: JMK, G-SC, JWJ
Visualization: SJJ
Writing–original draft: SJJ
Writing–review & editing: JR, JMK, G-SC, JWJ
Approval of final manuscript: all authors
Values are presented as number (%), median (interquartile range), or mean±standard deviation.
M, male; F, female; BMI, body mass index; ASA, American Society of Anesthesiologists; HCC, hepatocellular carcinoma; CRLM, colorectal cancer liver metastasis; C-sec, cesarean section; N/A, not applicable; MHV, middle hepatic vein; RHV, right hepatic vein; IVC, inferior vena cava; HCMP, hypertrophic cardiomyopathy.
OLR (n=229) | LLR (n=866) | P-value | |
---|---|---|---|
Age (years) | 62.0±11.3 | 59.9±11.5 | 0.012 |
Sex | |||
Male | 169 (73.8) | 622 (71.8) | |
Female | 60 (26.2) | 244 (28.2) | 0.610 |
BMI | 24.1±3.3 | 24.6±3.1 | 0.028 |
ASA | |||
1 | 12 (5.2) | 69 (8.0) | 0.340 |
2 | 181 (79.0) | 680 (78.5) | |
3 | 36 (15.7) | 113 (13.0) | |
4 | 0 (0.0) | 4 (0.5) | |
Child-Pugh score | |||
A | 227 (99.1) | 864 (99.8) | 0.195 |
B | 2 (0.9) | 2 (0.2) | |
Previous surgical history | |||
Number of abdominal operation | |||
None | 153 (66.8) | 624 (72.1) | 0.079 |
1 | 61 (26.6) | 196 (22.6) | |
2 | 9 (3.9) | 39 (4.5) | |
3 | 6 (2.6) | 7 (0.8) | |
Type of previous surgery | |||
None | 153 (66.8) | 624 (72.1) | |
Hepatectomy | 37 (16.2) | 51 (5.9) | <0.001 |
Upper gastrointestinal surgery | 18 (7.9) | 37 (4.3) | |
Lower gastrointestinal surgery | 10 (4.4) | 94 (10.9) | |
Genito-urinary surgery | 11 (4.8) | 60 (6.9) | |
Tumor characteristics | |||
Tumor location | |||
Posterior superior | 116 (50.7) | 376 (43.4) | 0.060 |
Anterolateral | 113 (49.3) | 490 (56.6) | |
Histologic subtype | |||
Hepatocellular carcinoma | 176 (76.9) | 596 (68.8) | <0.001 |
Cholangiocarcinoma | 19 (8.3) | 29 (3.3) | |
Metastatic tumor | 16 (7.0) | 104 (12.0) | |
Benign tumor | 15 (6.6) | 137 (15.8) | |
Other malignancy | 3 (1.3) | 0 (0.0) | |
Maximum tumor size (cm) | 4.8 (2.7-9.5) | 2.8 (2.0-4.5) | <0.001 |
Number of tumor | |||
1 | 175 (76.4) | 725 (83.7) | 0.034 |
2 | 30 (13.1) | 87 (10.0) | |
3 | 13 (5.7) | 31 (3.6) | |
>3 | 11 (4.8) | 23 (2.7) | |
Operation-related characteristics | |||
Resection extent | |||
Subsegmentectomy | 20 (8.7) | 170 (19.6) | <0.001 |
Segmentectomy | 29 (12.7) | 166 (19.2) | |
Bisegmentectomy | 30 (13.1) | 233 (26.9) | |
Hemihepatectomy or more | 150 (65.5) | 297 (34.3) | |
Operative time | 187.0 ± 56.6 | 155.8 ± 61.0 | <0.001 |
Estimated blood loss | 300.0 (200.0-450.0) | 165.0 (100.0, 300.0) | <0.001 |
Transfusion (RBC) | |||
Yes | 18 (7.9) | 9 (1.0) | |
No | 211 (92.1) | 857 (99.0) | <0.001 |
Postoperative outcome | |||
ICU stay (days) | 0.5±1.6 | 0.1±1.1 | 0.003 |
Hospital stay (days) | 15.3±8.6 | 9.6±8.6 | <0.001 |
OLR (n=116) | LLR (n=376) | P-value | |
---|---|---|---|
Age (years) | 61.2±10.5 | 59.9±11.5 | 0.235 |
Sex | |||
Male | 89 (76.7) | 269 (71.5) | |
Female | 27 (23.3) | 107 (28.5) | 0.329 |
BMI | 24.3±3.3 | 24.6±3.1 | 0.303 |
ASA | |||
1 | 6 (5.2) | 33 (8.8) | 0.585 |
2 | 93 (80.2) | 292 (77.7) | |
3 | 17 (14.7) | 50 (13.3) | |
4 | 0 (0.0) | 1 (0.3) | |
Child-Pugh score | |||
A | 114 (98.3) | 375 (99.7) | 0.140 |
B | 2 (1.7) | 1 (0.3) | |
Previous surgical history | |||
Number of abdominal operation | |||
None | 86 (74.1) | 279 (74.2) | 0.266 |
1 | 23 (19.8) | 76 (20.2) | |
2 | 4 (3.4) | 19 (5.1) | |
3 | 3 (2.6) | 2 (0.5) | |
Type of previous surgery | |||
None | 86 (74.1) | 279 (74.2) | |
Hepatectomy | 12 (10.3) | 21 (5.6) | 0.083 |
Upper gastrointestinal surgery | 6 (5.2) | 13 (3.5) | |
Lower gastrointestinal surgery | 4 (3.4) | 36 (9.6) | |
Genitourinary surgery | 8 (6.9) | 27 (7.2) | |
Tumor characteristics | |||
Histologic subtype | |||
Hepatocellular carcinoma | 93 (80.2) | 265 (70.5) | 0.007 |
Cholangiocarcinoma | 5 (4.3) | 8 (2.1) | |
Metastatic tumor | 10 (8.6) | 47 (12.5) | |
Benign tumor | 7 (6.0) | 56 (14.9) | |
Other malignancy | 1 (0.9) | 0 (0.0) | |
Maximum tumor size (cm) | 6.3 (3.3-10.2) | 2.9 (2.0-4.7) | <0.001 |
Number of tumor | |||
1 | 84 (72.4) | 298 (79.3) | 0.367 |
2 | 18 (15.5) | 44 (11.7) | |
3 | 6 (5.2) | 19 (5.1) | |
>3 | 8 (6.9) | 15 (4.0) | |
Operation-related characteristics | |||
Resection extent | |||
Subsegmentectomy | 6 (5.2) | 71 (18.9) | <0.001 |
Segmentectomy | 15 (12.9) | 65 (17.3) | |
Bisegmentectomy | 14 (12.1) | 92 (24.5) | |
Hemihepatectomy or more | 81 (69.8) | 148 (39.4) | |
Operative time | 190.6±63.4 | 176.2±59.0 | 0.031 |
Estimated blood loss | 300.0 (150.0, 505.0) | 200.0 (100.0, 300.0) | <0.001 |
Transfusion (RBC) | |||
Yes | 10 (8.6) | 6 (1.6) | |
No | 106 (91.4) | 370 (98.4) | 0.001 |
Postoperative outcome | |||
ICU stay (days) | 0.4±1.3 | 0.2±1.6 | 0.096 |
Hospital stay (days) | 13.0 (11.0-18.0) | 9.0 (8.0-10.0) | <0.001 |
Open conversion (n=14) | Non-open conversion (n=852) | P-value | |
---|---|---|---|
Age (years) | 59.2±12.5 | 59.9±11.4 | 0.836 |
Sex | |||
Male | 11 (78.6) | 611 (71.7) | |
Female | 3 (21.4) | 241 (28.3) | 0.768 |
BMI | 24.4±4.4 | 24.6±3.1 | 0.873 |
ASA | |||
1 | 0 (0.0) | 69 (8.1) | 0.232 |
2 | 10 (71.4) | 670 (78.6) | |
3 | 4 (28.6) | 109 (12.8) | |
4 | 0 (0.0) | 4 (0.5) | |
Child-Pugh score | |||
A | 13 (92.9) | 851 (99.9) | 0.032 |
B | 1 (7.1) | 1 (0.1) | |
Previous surgical history | |||
Number of abdominal operation | |||
None | 5 (35.7) | 619 (72.7) | <0.001 |
1 | 3 (21.4) | 193 (22.7) | |
2 | 6 (42.9) | 33 (3.9) | |
3 | 0 (0.0) | 7 (0.8) | |
Type of previous surgery | |||
None | 5 (35.7) | 619 (72.7) | |
Hepatectomy | 1 (7.1) | 50 (5.9) | 0.011 |
Upper gastrointestinal surgery | 1 (7.1) | 36 (4.2) | |
Lower gastrointestinal surgery | 4 (28.6) | 90 (10.6) | |
Genitourinary surgery | 3 (21.4) | 57 (6.7) | |
Tumor characteristics | |||
Tumor location | |||
Posterior superior | 12 (85.7) | 364 (42.7) | 0.003 |
Anterolateral | 2 (14.3) | 488 (57.3) | |
Histologic subtype | |||
Hepatocellular carcinoma | 8 (57.1) | 588 (69.0) | 0.317 |
Cholangiocarcinoma | 0 (0.0) | 29 (3.4) | |
Metastatic tumor | 4 (28.6) | 100 (11.7) | |
Benign tumor | 2 (14.3) | 135 (15.8) | |
Maximum tumor size (cm) | 6.8±8.8 | 3.9±3.3 | 0.241 |
Number of tumor | |||
1 | 8 (57.1) | 717 (84.2) | 0.015 |
2 | 3 (21.4) | 84 (9.9) | |
3 | 1 (7.1) | 30 (3.5) | |
>3 | 2 (14.3) | 21 (2.5) | |
Operation-related characteristics | |||
Resection extent | |||
Subsegmentectomy | 1 (7.1) | 169 (19.8) | 0.629 |
Segmentectomy | 2 (14.3) | 164 (19.2) | |
Bisegmentectomy | 5 (35.7) | 228 (26.8) | |
Hemihepatectomy or more | 6 (42.9) | 291 (34.2) | |
Operative time | 243.9±52.4 | 154.3±60.1 | <0.001 |
Estimated blood loss | 500.0 (250.0-887.5) | 150.0 (100.0-300.0) | <0.001 |
Transfusion (RBC) | |||
Yes | 2 (14.3) | 7 (0.8) | |
No | 12 (85.7) | 845 (99.2) | 0.008 |
Postoperative outcome | |||
ICU stay (day) | 0.5±0.9 | 0.1±1.1 | 0.114 |
Hospital stay (day) | 12.0 (10.0-19.0) | 9.0 (7.0-10.0) | <0.001 |
Case | Sex | Age | BMI | ASA | Diagnosis | Cause of open conversion | Number of previous operation | Details of previous operation | Tumor location | Maximum tumor size (cm) | Tumor number | Surgical margin (mm) | Open time (min) | Proximity to major vessel (vessel, mm) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | M | 56 | 28.7 | 2 | HCC | 1. Unfavorable anatomy for laparoscopy | 0 | S4, 8 | 1.6 | 1 | 5 | 139 | MHV, 18 | |
2. Bleeding | ||||||||||||||
2 | F | 47 | 25.7 | 2 | Hemangioma | Remnant tumor on margin | 2 | 1. C-sec | S5, 6, 7, 8 | 34 | 1 | N/A | 11 | abutting MHV, RHV |
2. C-sec | ||||||||||||||
3 | F | 55 | 19.8 | 2 | HCC | 1. Tumor rupture status | 0 | S5, 8 | 6.7 | 2 | 15 | 54 | MHV, 14 | |
2. Diaphragm invasion | ||||||||||||||
4 | M | 30 | 31.2 | 2 | CRLM | Poor visualization | 1 | 1. Laparoscopic right hemicolectomy | S4, 6, 7, 8 | 3.2 | >3 | 10 | 98 | RHV, 7 |
5 | M | 78 | 23.8 | 2 | HCC | Severe adhesion | 2 | 1. Bowel obstruction | S7 | 3.1 | 1 | 35 | 5 | RHV, 7 |
2. Prostate cancer | ||||||||||||||
6 | F | 54 | 29.1 | 2 | CRLM | Severe adhesion | 2 | 1. Hysterectomy | S6, 7, 8 | 2.3 | >3 | 10 | 19 | RHV, 7 |
2. Right hemicolectomy with duodenum wedge resection | ||||||||||||||
7 | M | 52 | 16.0 | 2 | Hemangioma | Severe adhesion | 1 | Anterior resection | S6, 7, 8 | 8.2 | 2 | 1 | 8 | Abutting RHV, MHV |
8 | M | 69 | 22.3 | 2 | CRLM | Severe adhesion | 1 | Laparoscopic extended right hemicolectomy | S7 | 2.5 | 1 | 13 | 6 | MHV 16 |
9 | M | 71 | 24.0 | 3 | HCC | Tumor adhesion with stomach | 1 | Laparoscopic cholecystectomy | S1 | 17.1 | 1 | N/A | 41 | Abutting IVC |
10 | M | 71 | 24.3 | 3 | HCC | Severe adhesion | 1 | Total gastrectomy | S6, 7 | 2.6 | 2 | 15 | 25 | Abutting RHV |
11 | M | 60 | 20.7 | 2 | HCC | Severe adhesion | 0 | S7 | 2.6 | 1 | 1 | 57 | Abutting RHV, MHV | |
12 | M | 69 | 25.2 | 2 | CRLM | Severe adhesion | 2 | 1. Laparoscopic low anterior resection | S1 | 2.5 | 3 | 2 | 34 | Portal bifurcation, 29 |
2. Laparoscopic extended left hemihepatectomy | ||||||||||||||
13 | M | 51 | 20.1 | 3 | HCC | Bleeding | 2 | 1. Kidney transplantation | S6, 7 | 4.1 | 1 | 15 | 103 | RHV, 9 |
2. Graftectomy | ||||||||||||||
14 | M | 66 | 30.2 | 3 | HCC | 1. Bleeding | 0 | S6, 7 | 4.2 | 1 | 19 | 137 | RHV, 22 | |
2. HCMP patient |
Values are presented as number (%), median (interquartile range), or mean±standard deviation. OLR, open liver resection; LLR, laparoscopic liver resection; BMI, body mass index; ASA, American Society of Anesthesiologists; RBC, red blood cell; ICU, intensive care unit.
Values are presented as number (%), median (interquartile range), or mean±standard deviation. OLR, open liver resection; LLR, laparoscopic liver resection; BMI, body mass index; ASA, American Society of Anesthesiologists; RBC, red blood cell; ICU, intensive care unit.
Values are presented as number (%), median (interquartile range), or mean±standard deviation. LLR, laparoscopic liver resection; BMI, body mass index; ASA, American Society of Anesthesiologists; RBC, red blood cell; ICU, intensive care unit.
Values are presented as number (%), median (interquartile range), or mean±standard deviation. M, male; F, female; BMI, body mass index; ASA, American Society of Anesthesiologists; HCC, hepatocellular carcinoma; CRLM, colorectal cancer liver metastasis; C-sec, cesarean section; N/A, not applicable; MHV, middle hepatic vein; RHV, right hepatic vein; IVC, inferior vena cava; HCMP, hypertrophic cardiomyopathy.